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Infectious bronchitis (IB) is a highly contagious respiratory, urogenital and reproduction 
disease of chickens and it is distributed worldwide.  The disease is caused by infectious 
bronchitis virus (IBV).  IBV is a member of the genus Coronavirus, family 
Coronaviridae and it has a single-stranded, positive-sense RNA genome of 27.6 kb.  It 
possesses prominent surface spikes and has three major structural proteins; the spike (S) 
glycoprotein, the small integral membrane (M) glycoprotein and nucleocapsid (N) 
protein.  In the commercial poultry industry, vaccination is used to control the disease.  
Despite vaccination program the disease continues to occur because IBV can exist in 
many serotypes.  In many incidences, the existing vaccines are not able to provide full 
protection to the chickens against infectious bronchitis disease. The immune response 
stimulated to one serotype does not offer cross protection to another serotype.  Moreover, 
the avian coronavirus capable of mutating and many IBV variants has been reported in 
many countries.  Thus, it is crucial to develop a fast, sensitive and specific diagnostic 
technique to diagnose and identify the causative agent in order to control the disease 
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spread.  In recent years the reverse transcriptase-polymerase chain reaction (RT-PCR), 
reverse transcriptase-polymerase chain reaction-restriction fragment length 
polymorphism (RT-PCR-RFLP), cloning and genes sequencing had been used 
increasingly to detect and analyses IBV isolates.  The objectives of these studies were to 
compare and optimize reverse transcriptase-polymerase chain reaction (RT-PCR) to 
diagnose IBV, to differentiate the Mass strain, and to characterize variant IBV isolated 
from this study.  In this study, one-step and two-step RT-PCR techniques were used to 
amplify the conserved gene region of IBV by using universal and designed primers.  This 
study was conducted on IBV isolates from year 1991 until 2003.  In differentiation 
studies, isolates were group into serotype using reverse transcriptase-polymerase chain 
reaction (RT-PCR).  Isolates recognized to be non Mass was further amplified their 
hypervariable region of S gene by using RT-PCR followed by RFLP technique to screen 
for nephropathogenic strain.  Out of 31 IBV isolates, nine Mass strain were found.  
Following RT-PCR-RFLP, only one isolate showed different fragment pattern compared 
to nephropathogenic origin (MH5365/95).  This particular isolates designated as V9/03 
was neither Mass nor non-nephropathogenic serotype.   The S1 region of V9/03 was 
further cloned, sequenced and its nucleotide and amino acid were compared to 
nephropathogenic MH5365/95 and Mass derivatives as well other references strains 
obtained from Gene bank.  The V9/03 showed sequence homology to Taiwan 
(AY606321) and Korean (AY257060) strain with 82.5% and 81.6% identities 
respectively.  The V9/03 has lower sequences homology (less than 80%) with 
nephropathogenic (MH5365/95) and Mass derivatives.  The phylogenetic studies indicate 
that the strain V9/03 could be a local variant IBV which is different from local 
 iv
nephropathogenic MH5365/95 and vaccine strain.  This study showed that variant IBV is 
circulating in the field as result of mutation of IBV due to the prolonged use of live virus 
vaccines and the immunological pressure of the virus to keep on survival in immune 
birds.  
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Bronkitis berjangkit merupakan penyakit pernafasan ayam yang menular ke serata dunia.  
Ianya disebabkan oleh virus bronkitis berjangkit (IBV).  Virus bronkitis berjangkit (IB) 
merupakan ahli genera Coronavirus, famili Coronaviridae.  Virus ini merupakan virus 
bebenang tunggal, RNA genom berpancaindera-positif bersaiz 27.6 kb.  Ianya 
mempunyai permukaan tajam yang menonjol dan mempunyai tiga protein berstruktur 
yang utama; glikoprotein pepaku (S), glikoprotein membran kecil perlu (M) dan protein 
nukleokapsid (N).  Dalam industri penternakan ayam, vaksinasi digunakan untuk 
mengawal penyakit.  Walaupun program vaksinasi, penyakit terus berlaku kerana IBV 
boleh wujud di dalam pelbagai serotip.  Dalam kebanyakkan kejadian, kewujudan vaksin-
vaksin sahaja tidak mencukupi untuk menyediakan perlindungan sepenuhnya kepada 
ayam-ayam bagi menentang IBV.  Tindakbalas imuniti terhadap satu serotip tidak boleh 
menawarkan perlindungan bersilang kepada serotip yang lain.  Lagipun, coronavirus 
avian berkebolehan untuk mutasi dan banyak varian IBV telah dilaporkan di beberapa 
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negara.  Demikian, adalah sangat genting agen penyebab dikenalpasti untuk mengawal 
penyebaran penyakit.  Sejak akhir-ahir ini, RT-PCR, RT-PCR-RFLP, pengklonan dan 
penjujukan gen telah banyak digunakan untuk mengesan dan analisis isolat IBV.  
Objektif-objektif dalam kajian ini adalah untuk membina dan optimasi RT-PCR untuk 
diagnosa IBV, mengasingkan strain Mass dan untuk mengenalpasti IBV varian terpencil 
dalam kajian ini.  Dalam kajian ini, teknik satu langkah dan 2-langkah RT-PCR telah 
digunakan untuk menggandakan gen yang majmuk bagi IBV dengan menggunakan 
primer universal dan direka.  Kajian ini telah dijalankan ke atas isolat-isolat IBV dari 
tahun 1991-2003. Dalam kajian pengasingan, isolat-isolat telah dibahagikan kepada strain 
Mass dan bukan Mass.  Isolat bukan Mass telah digandakan gennya dan dilakukan RFLP 
untuk mengenalpasti strain nefropatogenik.  Sembilan daripada 30 isolat IBV adalah 
strain Mass, selebihnya dijangkakan nefropatogenik (MH5365/95) kecuali satu isolat.  
Isolat tersebut adalah V9/03.  Isolat ini telah dijujukkan dan mempunyai sedikit 
kesamaan dengan isolat dari Taiwan (AY) dan Korean (AY257060) with 82.5% dan 
81.6%.  The V9/03 mempunyai persamaan yang rendah (kurang dari 80% dengan 
nefropatogenik MH5365/95 dan terbitan Mass.  Analisis filogenetik menunjukkan V9/03 
adalah varian berbeza daripada nefropatogenik MH5365/95 and strain vaksin.  Kajian ini 
menunjukkan bahawa varian IBV berkitaran di ladang, sama seperti mutasi IBV 
disebabkan penggunaan vaksin virus hidup dalam tempoh yang berpanjangan dan 
tekanan imunologi virus untuk terus kekal dalam ayam-ayam yang imun.   
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CTP cytidine triphosphate  
ddH20 distilled deionized water 
DNA deoxyribonuclease acid 
dNTP deoxyribonucleotide triphosphate 
DTT dithiothreitol  
E.coli Escherichia coli 
EB elution buffer  
EDTA ethylenediaminetetraacetic acid 
ELISA enzyme-linked immunosorbent assay 
EMBL England Molecular Biology Laboratory 
GTP guanosine triphosphate 
HA haemagglutination 
HCl hydrochloride acid 
HI haemagglutination-inhibition 
IB infectious bronchitis 
IBV infectious bronchitis virus 
kb kilobase pair 
KCl kalium chloride 
kDa kilodalton 
l litre 
LB Luria Bertani 
M membrane 
MAb monoclonal antibody 
MVK Makmal Veterinar Kawasan Petaling Jaya 
MgCl2 Magnesium chloride 
MHV murine hepatits virus 
mM miliMolar 
Mo-MLV Moloney murine leukemia virus 
MOPS 3-N-morpholino propanesulfonic acid 
mRNA messenger RNA 
MVP Malaysian Vaccine Pharmaceutical 
N Nucleocapsid 
xxi 
 xxii
NaCl natrium chloride 
NDV New Castle disease virus 
NS Nonstructural 
ORF open reading frame 
PBS phosphate buffer saline 
PCR polymerase chain reaction 
pmol picomole 
RE restriction enzyme 
RNA ribonuclease acid 
RT-PCR reverse transcriptase-polymerase chain reaction 
RT-PCR-RFLP reverse transcriptase-polymerase chain reaction-restriction fragment 
length polymorphism 
S spike 
SDS Sodium Doedecyl Sulfate 
SgRNAs subgenomic mRNA 
sp signal peptide 
TBE Tris-borate EDTA buffer 
TTP thymidine triphosphate 
U unit 
UK United Kingdom 
UPM Universiti Putra Malaysia 
USA United States of America 
UTR untranslated region 
UV ultraviolet 
V/60 volt per 60 minutes 
VN virus neutralization 
VNT virus neutralization test 
VRI Veterinary Research Institute 
w/v weight per volume 
 
CHAPTER 1 
 
GENERAL INTRODUCTION 
 
Infectious bronchitis virus (IB) is an acute, highly contagious respiratory and urogenital 
disease of chickens.  The disease, also called avian infectious bronchitis virus is of 
significant to the economic importance to the poultry industry as it causes poor weight 
gain and feed efficiency.  The disease was first reported in 1931 in the United State of 
America (Beach and Schalm, 1936).  It is one of the organisms isolated and produces air-
sacculitis resulting in condemnations of broilers at processing (King and Cavanagh, 
1991). 
 
IBV together with Turkey and pheasant coronaviruses, belongs to Group 3 of the genus 
Coronavirus, family Coronaviridae (Cavanagh, 2001).  All the members of this genus 
have a linear, non-segmented, positive sense, single stranded RNA genome of 
approximately 27 kb in length.  The first 20 kb encode the viral RNA-dependent RNA 
polymerase and proteases.  The remainder of the genome encodes five structural proteins, 
the spike (S) consisting S1 and S2, envelope (E), membrane (M) and nucleocapsid (N) 
proteins, four small non-structural proteins 3a, 3b, 5a and 5b and a 3’ untranslated region 
(UTR). 
 
Variations in the S1 and N genes, in particular, are believed to be critical for emergence 
of variants because of their role in virus replication and immunity.  Moreover, S1 and N 
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have been used most frequently to determine the relatedness of emerging IBV.  The S1 
glycoprotein is located on the surface of the virion ad carries epitopes and determinants 
for virus neutralizing antibodies, protective immunity and cell tropism (Casais et al., 
2003 ; Cavanagh et al., 1986 ; Cavanagh et al., 1988).  The N protein, located in the 
capsid of the virion in involved in RNA replication and carries group-specific antigenic 
determinants (Ignjatovic and Galli, 1995).  The 3’UTR region is involved in initiation of 
negative-strand RNA synthesis and has also been used to assess variation in emerging IB 
strains and other members of coronavirus Group 3 (William et al., 1993).  
 
IBV evolution is currently considered to be driven by three factors such as the inherent 
propensity of its RNA genome to mutate, the continuous use of live, often multiple 
vaccines and the immunological pressure exerted on circulating viruses by the enduring 
presence of immune bird populations.  These three factors probably role in performance 
and involve various mechanisms, such as point mutations, deletion, insertions and 
recombination to generate new variants (Cavanagh et al., 1992a ; Kuster et al., 1990 ; 
Wang et al., 1994). 
 
Serotyping of IBV isolate is essential in the design of prevention and control strategies as 
well as in epidemiological studies.  Several serotyping methods have been used including 
virus neutralization (VN) (Zwaagstra et al., 1992), reverse transcription-polymerase chain 
reaction-restriction fragment length polymorphism (RT-RFLP) (Kwon et al., 1993), 
serotype-specific reverse transcriptase-polymerase chain reaction (RT-PCR) (Lai and 
Cavangh, 1997) and multiplex PCR (Wang and Khan, 1999).  For the control of disease 
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